You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,230.7% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.5 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 36.0 | n/a |
| Price / Book value | 20.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 88.6% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 1.79 | -16.27 | $-0.23 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 2.57 | -50.08 | $-0.63 | -1.5 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 0.64 | -19.37 | $-0.10 | -2.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 1.20 | -14.41 | $-0.07 | -1.6 | 0.0 | n/a | n/a | 0.0% |
| Ondine Biomedical to start phase three Steriwave clinical trial Sharecast News | 17 Dec |
|---|---|
| Ondine raising £8.5m to fund US clinical trial Sharecast News | 01 Nov |
| Ondine Biomedical gets UAE approval for Steriwave Sharecast News | 18 Oct |
| Ondine commencing US Phase 3 clinical trial | 17-Dec-24 07:01 |
|---|---|
| Notification of Major Holdings | 25-Nov-24 17:00 |
| Notification of Major Holdings | 22-Nov-24 10:31 |
| Director Holdings | 22-Nov-24 08:30 |
| NOTIFICATION OF MAJOR HOLDINGS | 18-Nov-24 17:00 |